Chemical Component Summary

NameArtesunate
FormulaC19 H28 O8
Molecular Weight384.42
TypeNON-POLYMER
Isomeric SMILESC[C@@H]1CC[C@H]2[C@@H](C)[C@@H](O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4)OC(=O)CCC(O)=O
InChIInChI=1S/C19H28O8/c1-10-4-5-13-11(2)16(23-15(22)7-6-14(20)21)24-17-19(13)12(10)8-9-18(3,25-17)26-27-19/h10-13,16-17H,4-9H2,1-3H3,(H,20,21)/t10-,11-,12+,13+,16-,17-,18-,19-/m1/s1
InChIKeyFIHJKUPKCHIPAT-AHIGJZGOSA-N

Chemical Details

Formal Charge0
Atom Count55
Chiral Atom Count8
Bond Count58
Aromatic Bond Count0

Drug Info: DrugBank

DrugBank IDDB09274 
NameArtesunate
Groups
  • approved
  • investigational
DescriptionArtesunate is indicated for the initial treatment of severe malaria.[L14099] The World Health Organization recommends artesunate as first line treatment for severe malaria.[L890] Artesunate was developed out of a need for a more hydrophilic derivative of [artemisinin].[A203948] Artesunate was granted FDA approval on 26 May 2020.[L14099]
Synonyms
  • Succinyl dihydroartemisinin
  • Artesunate sodium
  • butanedioic acid, 1-[(3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-yl] ester
  • Artesunic acid
  • dihydroqinghasu hemsuccinate
IndicationArtesunate is indicated for the initial treatment of severe malaria in adult and pediatric patients.[L14099]
Categories
  • Acids, Acyclic
  • Anions
  • Anthelmintics
  • Anti-Infective Agents
  • Antimalarials
ATC-Code
  • P01BE03
  • P01BF02
  • P01BF03
  • P01BF06
  • P01BF04
CAS number88495-63-0

Drug Targets

NameTarget SequencePharmacological ActionActions
Malaria protein EXP-1MKILSVFFLVLFFIIFNKESLAEKTNKETGSGVSSKKKNKKGSGEPLIDV...unknowninhibitor
UDP-glucuronosyltransferase 2B7MSVKWTSVILLIQLSFCFSSGNCGKVLVWAAEYSHWMNIKTILDELIQRG...unknownsubstrate
UDP-glucuronosyltransferase 1-9MACTGWTSPLPLCVCLLLTCGFAEAGKLLVVPMDGSHWFTMRSVVEKLIL...unknownsubstrate
Cytochrome P450 2A6MLASGMLLVALLVCLTVMVLMSVWQQRKSKGKLPPGPTPLPFIGNYLQLN...unknownsubstrate
Serum albuminMKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...unknownbinder
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682